iSpecimen Introduces New Marketplace Functionality To Streamline Access To Clinical Remnant Samples For Researchers
iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today
Earnings Scheduled For August 2, 2023
Companies Reporting Before The Bell
• Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Enzo Biochem (NYSE:ENZ) stock moved upwards by 12.5% to $1.53 during Monday’s after-market session. The market value…
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Incannex Healthcare (NASDAQ:IXHL) stock rose 32.2% to $2.46 during Thursday’s pre-market session. The market value of their…
Looking Into iSpecimen’s Return On Capital Employed
Benzinga Pro data, iSpecimen (NASDAQ:ISPC) reported Q1 sales of $2.95 million. Earnings fell to a loss of $2.43…
iSpecimen: Q1 Earnings Insights
iSpecimen (NASDAQ:ISPC) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM. Here’s what investors…
iSpecimen Names Tracy Curley As Chief Executive Officer Effective Immediately
iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare
iSpecimen Q3 EPS $(0.35) Misses $(0.34) Estimate, Sales $2.58M Beat $2.45M Estimate
iSpecimen (NASDAQ:ISPC) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.34) by 2.94 percent. This is a 59.09 percent decrease over losses of $(0.22) per share from the